GLAXO/SPECTRA BIOMEDICAL MIGRAINE GENETICS COOPERATIVE VENTURE
Executive Summary
GLAXO/SPECTRA BIOMEDICAL MIGRAINE GENETICS COOPERATIVE VENTURE will focus initially on discovering the genetic bases for migraine using Spectra's proprietary SPECTRA-LINK database, the genetic diseases R&D company announced June 23. Based on the DNA database, Spectra will analyze the genomic linkage data aiming to correlate specific DNA sequences with migraines, which long have been known to have a genetic component.